Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
21K characters. Original on sec.gov · Markdown
Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
Information responsive to this Item is set forth in “Fees Paid to Independent Auditors” and “Audit Committee Pre-Approval Policies” of the definitive proxy statement for the Company’s annual meeting of stockholders to be filed on or before April 29, 2024, and is incorporated herein by reference.
PART IV
| Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES |
| (a)(1) | See Item 8, “Financial Statements and Supplementary Data,” for a list of financial statements. |
| (a)(2) | Financial statement schedules |
| SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS AND RESERVES | |||||||||||||||||||||||||||||
| Beginning of | End of | ||||||||||||||||||||||||||||
| (In millions) | Year Balance | Additions | Deductions (1) | Other (2) | Year Balance | ||||||||||||||||||||||||
| Allowance for doubtful accounts | |||||||||||||||||||||||||||||
| December 31, 2021 | $ | 100 | 32 | (28) | 18 | $ | 122 | ||||||||||||||||||||||
| December 31, 2022 | $ | 122 | 88 | (12) | 1 | $ | 199 | ||||||||||||||||||||||
| December 31, 2023 | $ | 199 | 6 | (28) | 38 | $ | 215 | ||||||||||||||||||||||
| Beginning of | End of | ||||||||||||||||||||||||||||
| (In millions) | Year Balance | Additions | Deductions | Other | Year Balance | ||||||||||||||||||||||||
| Income tax valuation allowance | |||||||||||||||||||||||||||||
| December 31, 2021 | $ | 339 | 7 | (65) | — | $ | 281 | ||||||||||||||||||||||
| December 31, 2022 | $ | 281 | 18 | (90) | — | $ | 209 | ||||||||||||||||||||||
| December 31, 2023 | $ | 209 | 58 | (51) | — | $ | 216 | ||||||||||||||||||||||
| (1) Uncollectible accounts written off | |||||||||||||||||||||||||||||
| (2) Impact of reclassifications, foreign exchange translation, and other adjustments |
All other schedules are either not required, not applicable, or the information is otherwise included.
| (a)(3) | List of exhibits |
(3ii)Bylaws, as amended through November 2, 2022 (incorporated by reference to Exhibit (3ii) to the Company’s Annual Report on Form 10-K filed on February 14, 2023).
| Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES (Continued) |
(4)Instruments defining the rights of security holders, including:
(i)Description of Securities of Registrant
(ii)Indenture, dated as of June 1, 1986, by and between the Company and The Bank of New York Mellon (successor to JPMorgan Chase, The Chase Manhattan Bank, Chemical Bank, and Manufacturers Hanover Trust Company), as Trustee (incorporated by reference to Exhibit 4(a) to the Company’s Registration Statement on Form S-3 (File No. 33-6721)), as amended and supplemented by Supplemental Indenture, dated as of August 1, 1989, by and between the Company and The Bank of New York Mellon (successor to JPMorgan Chase, The Chase Manhattan Bank, Chemical Bank and Manufacturers Hanover Trust Company), as Trustee (incorporated by reference to Exhibit 4(c) to Post Effective Amendment No. 3 to the Company’s Registration Statement on Form S-3 (No. 33-6721)), relating to:
the $350,000,000 – 7 1/2% Debentures due March 15, 2027,
the $200,000,000 – 6 3/4% Debentures due December 15, 2027,
the $300,000,000 – 6 5/8% Debentures due May 1, 2029,
the $400,000,000 – 7% Debentures due February 1, 2031,
the $500,000,000 – 5.935% Debentures due October 1, 2032,
the $600,000,000 – 5.375% Debentures due September 15, 2035, and
the $250,000,000 – 6.95% Debentures due December 15, 2097.
(iii)Indenture, dated as of September 20, 2006, by and between the Company and The Bank of New York Mellon, as successor to JPMorgan Chase Bank, N.A., as Trustee (incorporated by reference to Exhibit 4 to the Company’s Registration Statement on Form S-3), as amended and supplemented by First Supplemental Indenture, dated as of June 3, 2008, by and between the Company and The Bank of New York Mellon (formerly known as The Bank of New York) (incorporated by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on June 3, 2008), Second Supplemental Indenture, dated as of November 29, 2010, by and between the Company and The Bank of New York Mellon (incorporated by reference to Exhibit 4.3 to the Company’s Current Report on Form 8-K filed on November 30, 2010), and Third Supplemental Indenture, dated as of April 4, 2011, between the Company and The Bank of New York Mellon (incorporated by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on April 8, 2011), relating to:
the $500,000,000 – 6.45% Debentures due January 15, 2038,
the $1,000,000,000 – 5.765% Debentures due March 1, 2041, and
the $527,688,000 – 4.535% Debentures due March 26, 2042.
(iv)Indenture, dated as of October 16, 2012, by and between the Company and The Bank of New York Mellon, as Trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on October 17, 2012), relating to:
the $570,425,000 – 4.016% Debentures due April 16, 2043,
the €600,000,000 – 1.750% Notes due June 23, 2023,
the $1,000,000,000 – 2.500% Notes due August 11, 2026,
the $500,000,000 – 3.750% Notes due September 15, 2047,
the €650,000,000 – 1.00% Notes due September 12, 2025,
the $600,000,000 – 4.500% Notes due March 15, 2049,
the $1,000,000,000 – 3.250% Notes due March 27, 2030,
the $750,000,000 – 3.250% Notes due September 15, 2051,
the $750,000,000 – 2.900% Notes due March 1, 2032, and
the $500,000,000 – 4.500% Notes due August 15, 2033
(v)Indenture, dated as of July 26, 2023, by and between the Company and Deutsche Bank Trust Company Americas, as Trustee (incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form S-3 filed on July 26, 2023).
| Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES (Continued) |
(vi)Copies of constituent instruments defining rights of holders of long-term debt of the Company and its Subsidiaries, other than the indentures specified herein, are not filed herewith, pursuant to Instruction (b)(4)(iii)(A) to Item 601 of Regulation S-K, because the total amount of securities authorized under any such instrument does not exceed 10% of the total assets of the Company and Subsidiaries on a consolidated basis. The Company hereby agrees that it will, upon request by the SEC, furnish to the SEC a copy of each such instrument.
(10)Copies of the Company’s equity compensation plans, deferred compensation plans and agreements with executive officers are incorporated herein by reference pursuant to Instruction (b)(10)(iii)(A) to Item 601 of Regulation S-K, each of which is a management contract or compensation plan or arrangement required to be filed as an exhibit pursuant to Item 15(b) of Form 10-K, as follows:
| Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES (Continued) |
(xvii)Form of Restricted Stock Unit Award Agreement for International Employees under the Company’s 2009 Incentive Compensation Plan (incorporated by reference to Exhibit 10(vi) to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2013).
Previous: Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE · Next: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES (Continued)